Skip to content

Deep Dive Randomized Control Trial

Deep Dive Randomized Control Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00793260
Enrollment
174120
Registered
2008-11-19
Start date
2006-07-31
Completion date
2008-05-31
Last updated
2008-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis, Chronic Disease, Preventive Health Services, Spinal Diseases, Uterine Diseases

Brief summary

Compare two care management support program models on medical costs and utilization.

Interventions

The Enhanced-Support Group program used lower risk thresholds for targeted outreach of individuals with chronic illness and for those likely to face discrete surgical interventions. Individuals at high financial risk but without one of the five chronic conditions were included in the Enhanced-Support Group. The Enhanced-Support Group received up to five initial reach attempts while the Usual-Support Group received up to three attempts. The Enhanced-Support Group used a 'tight loop' management structure including detailed, timely coach level feedback reports on efficiency and effectiveness.

BEHAVIORALUsual-Support

Predictive models in the Usual-Support Group were aimed at identifying individuals through medical claims and administrative data (such as hospitalization notification). The output of the predictive models is a rank-ordered, or stratified, list of individuals who have support needs. These lists were then used to generate outbound mail, interactive voice response (IVR) calls or calls by health coaches.

Sponsors

Health Net California
CollaboratorUNKNOWN
Highmark Blue Cross Blue Shield
CollaboratorUNKNOWN
Health Dialog
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* All employees, dependents and retirees in one of seven large employer groups, including a state university system, a state employee group, two manufacturing companies, a natural resource extraction company, a public educational service agency, and a nonprofit multiple employer association for independent colleges were eligible for inclusion.

Exclusion criteria

* no financial information was available from their facility and professional claims; * they were in an employer sub-group ineligible for care support services; * they asked not be to contacted or were deceased; * gender information was missing from their eligibility files; * their claims data from the year prior to the start of the study indicated diagnoses of HIV, AIDS, end-stage renal disease (ESRD), organ transplants, or necrotizing fasciitis (intended to improve the likelihood of a balanced distribution of costs and conditions); OR * they were in an employer sub-group with less than four months of enrollment prior to the study start date (resulting in too little information for stratification).

Design outcomes

Primary

MeasureTime frame
The primary outcome measure was total medical costs (capped at $200,000 per individual per year) and pharmacy costs.

Secondary

MeasureTime frame
Secondary measures included utilization of selected services.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 30, 2026